Prabhavathi Fernandes

Board Director

Director

Insider activity · 24 months1 buy0 salesCumulative net flow

Nov 24 · 1 buy · 0 salesDec 24 · 0 buys · 0 salesJan 25 · 0 buys · 0 salesFeb 25 · 0 buys · 0 salesMar 25 · 0 buys · 0 salesApr 25 · 0 buys · 0 salesMay 25 · 0 buys · 0 salesJun 25 · 0 buys · 0 salesJul 25 · 0 buys · 0 salesAug 25 · 0 buys · 0 salesSept 25 · 0 buys · 0 salesOct 25 · 0 buys · 0 salesNov 25 · 0 buys · 0 salesDec 25 · 0 buys · 0 salesJan 26 · 0 buys · 0 salesFeb 26 · 0 buys · 0 salesMar 26 · 0 buys · 0 salesApr 26 · 0 buys · 0 salesMay 26 · 0 buys · 0 salesJun 26 · 0 buys · 0 salesJul 26 · 0 buys · 0 salesAug 26 · 0 buys · 0 salesSept 26 · 0 buys · 0 salesOct 26 · 0 buys · 0 sales

Total declarations

Companies

▲ Purchases (1 ops.)

€8,708

▼ Sales (0 ops.)

—

Latest filing published 02 Dec 2024 for Ocugen, Inc., €8,708. Read the official filing

Filing timeline

BuySale

Prabhavathi Fernandes

Insider track record

Disclosed buys

Disclosed sells

T+90 hit rate

T+90 mean return

-12.3%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

Prabhavathi Fernandes: trading record in brief

Prabhavathi Fernandes is a declared insider at 2 companies (board member); the most frequent names are CapForce Inc. and Ocugen, Inc. We count 5 filings; the first trade dates from 25 May 2021 and the latest from 26 November 2024.

Every open-market trade on record is a purchase: 1 purchase worth €8,708, and no sale. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 3 share grants and 1 option exercise. In 2024 alone, the filings show 1 purchase and no sales.

On 2 December 2024 came the latest disclosure, an open-market purchase for €8,708 in Ocugen, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.